Randomized, Double-Blind, Controlled Trial of Nebulized Budesonide, Epinephrine and Salbutamol in Infants with Acute Bronchiolitis

Read full text Summarise with VIRAT
Authors: Betül Karaatmaca, Metin Aydoğan, Dilek Yavuzcan Öztürk, Rengin Şiraneci
Cited by: 0
References: 30

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

What is known on this subject?Acute bronchiolitis remains a leading cause of pediatric lower respiratory tract infections, characterized by a highly variable clinical course.While it is a common diagnosis, the optimal management strategy is still a matter of significant debate.In particular, the clinical utility and therapeutic benefit of bronchodilators remain uncertain, leading to substantial variations in clinical practice. What this study adds?This study establishes that nebulized salbutamol, epinephrine, and budesonide provide no significant therapeutic advantage over normal saline in the management of infants with mild bronchiolitis.Comparative analysis reveals that while long-term outcomes remain unaffected, nebulized salbutamol may offer a modest clinical benefit in achieving shortterm symptomatic improvement compared to other nebulized modalities.

Fields of Study & Subjects

Respiratory viral infections research Pediatric health and respiratory diseases Pneumonia and Respiratory Infections

Publication details

Journal / source
Cam and Sakura Medical Journal
Volume
6
Issue
2
Publication date
31 March 2026
Language
EN